Display Settings:

Format

Send to:

Choose Destination
    J Subst Abuse Treat. 2010 Jan;38(1):12-21. Epub 2009 Jul 1.

    A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification.

    Source

    Harvard Medical School, Department of Psychiatry, Boston, MA 02115, USA. christina.meade@duke.edu

    Abstract

    This pilot study tested the effectiveness of transcutaneous electric acupoint stimulation (TEAS) as an adjunctive treatment for inpatients receiving opioid detoxification with buprenorphine-naloxone at a private psychiatric hospital. Participants (N = 48) were randomly assigned to active or sham TEAS and received three 30-minute treatments daily for 3 to 4 days. In active TEAS, current was set to maximal tolerable intensity (8-15 mA); in sham TEAS, it was set to 1 mA. By 2 weeks postdischarge, participants in active TEAS were less likely to have used any drugs (35% vs. 77%, p < .05). They also reported greater improvements in pain interference (F = 4.52, p < .05) and physical health (F = 4.84, p < .01) over time. TEAS is an acceptable, inexpensive adjunctive treatment that is feasible to implement on an inpatient unit and may be a beneficial adjunct to pharmacological treatments for opioid detoxification.

    PMID:
    19574017
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2789908
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 1
    Figure 2

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk